AzTrials
AzTrials

Peripheral Arterial Disease, Ankle Brachial Index, DopplerABIOSCILLONCT03511612

Comparison of the Ankle-Brachial Index Measurement Using a Specific Oscillometric Device vs. the Doppler Method

A study testing Measure ankle brachial index (ABI) in people with Peripheral Arterial Disease, Ankle Brachial Index, Doppler, run by University Hospital, Limoges at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Several methods are available to measure ankle brachial index (ABI) non-invasively. A recent scientific statement of the AHA considers the Doppler method as the reference. However because Doppler devices are not widely available in primary care, several attempts have been made to propose alternative methods, among… Read more about this study

Who is it for?
Ages 60 years and older
What is being tested?
Measure ankle brachial index (ABI)
Could I receive a placebo?
No, everyone receives an active treatment
How many people
51 participants
Where
1 siteFrance
Study dates
24 Apr 2018to 24 Oct 2018
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 60 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patients referred with the suspicion of PAD, either because of:
  • symptoms in favor of intermittent claudication or more atypical pain when walking, or
  • asymptomatic individuals with the presence of at least 2 cardiovascular risk factors among the following :
  • Men > 60 years or women > 65 years
  • Regular cigarette smoking >10 years, either current or in the past
  • Treated Type-2 diabetes >5 years or Type-1 diabetes >20 years
Show all 10Show fewer
  • Treated hypertension
  • High blood cholesterol (either total-C >240 mg/dl or LDL-C >160 mg/dl) or treated by statins or other lipid-lowering agents
  • Documented history of coronary artery disease (history of PCI or CABG, or previous myocardial infarction, or CAD documented by coronary angiography)
  • Documented history of ischemic stroke

Who cannot join

  • Patients with revascularized PAD
  • Patients with critical limb ischemia or leg/foot ulcers
  • Cardiac arrhythmia: Atrial fibrillation, atrial flutter, frequent supra- and ventricular ectopic beats
  • Patients under dialysis

Trial locations and contacts

1 site in 1 country.

France1 site
  • University Hospital

    Limoges, 87200

Other trials in France

About this study

Several methods are available to measure ankle brachial index (ABI) non-invasively. A recent scientific statement of the AHA considers the Doppler method as the reference. However because Doppler devices are not widely available in primary care, several attempts have been made to propose alternative methods, among whom oscillometric methods (automatic blood pressure machines) have attracted most attention.

We hypothesize that:

  • the diagnostic characteristics (i.e. sensitivity, specificity and AUC) of the oscillometric method would be very good as compared to the Doppler method. the oscillometric method would have better intra- and inter-observer reproducibilities as compared to the Doppler method.
Being tested
Measure ankle brachial index (ABI)
Medical subject headings
Peripheral Arterial Disease

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Measure ankle brachial index (ABI)Diagnostic test

    This is a head-to-head comparison of 2 methods of determination of the ABI, taking the Doppler method as the standard and the oscillometric device AVP as the challenger

Study groups in NCT03511612
Study groupRoleWhat they receive
Pattern AOtherIntervention : Each subject has 3 measurements of ABI starting with oscillometric device and then using the Doppler method.
Receives: Diagnostic Test: Measure ankle brachial index (ABI)
Pattern BOtherIntervention : Each subject has 3 measurements of ABI starting with Doppler method and then using oscillometric device.
Receives: Diagnostic Test: Measure ankle brachial index (ABI)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Measurement of the ABI

    Measurement of the ABI, with Doppler method as reference

    Measured: Day of the inclusion

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted30 Apr 2018
  2. Study start24 Apr 2018
  3. Primary completion24 Oct 2018
  4. Study completion24 Oct 2018

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Diagnosis
Allocation
Non-randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
51 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03511612
Sponsor's protocol ID
87RC17_0075 (ABIOSCILLO)
Acronym
ABIOSCILLO
Status last verified
Jul 2025
First submitted
18 Apr 2018
Last updated
1 Aug 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Ichihashi S, Desormais I, Hashimoto T, Magne J, Kichikawa K, Aboyans V. Accuracy and Reliability of the Ankle Brachial Index Measurement Using a Multicuff Oscillometric Device Versus the Doppler Method. Eur J Vasc Endovasc Surg. 2020 Sep;60(3):462-468. doi: 10.1016/j.ejvs.2020.06.013. Epub 2020 Aug 3.

    PubMed 32763120

Questions about this trial

What is this clinical trial studying?

A study testing Measure ankle brachial index (ABI) in people with Peripheral Arterial Disease, Ankle Brachial Index, Doppler, run by University Hospital, Limoges at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 10 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 1 Aug 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Measurement of the ABI (time frame: Day of the inclusion). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03511612, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 1 Aug 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in